- Autori:
-
Valenti, Maria Teresa; Giannini, S; Donatelli, Luca; Zanatta, Mirko; Bertoldo, Francesco; Sella, S; Vilei, Mt; Ossi, E; Realdi, G; LO CASCIO, Vincenzo; DALLE CARBONARE, Luca Giuseppe
- Titolo:
-
The effect of risedronate on osteogenic lineage is mediated by cyclooxygenase-2 gene upregulation
- Anno:
-
2010
- Tipologia prodotto:
-
Articolo in Rivista
- Tipologia ANVUR:
- Articolo su rivista
- Lingua:
-
Inglese
- Formato:
-
Elettronico
- Referee:
-
Sì
- Nome rivista:
- ARTHRITIS RESEARCH & THERAPY
- ISSN Rivista:
- 1478-6362
- N° Volume:
-
12
- Numero o Fascicolo:
-
4
- Intervallo pagine:
-
R163-R176
- Parole chiave:
-
COX-2; glucocorticoids; histomorphometry; osteoporosis; risedronate
- Breve descrizione dei contenuti:
- Introduction: The purpose of this study was to evaluate the effects of risedronate (Ris) in the modulation of bone
formation in rats with glucocorticoid (GC)-induced osteoporosis by histomorphometric, immunohistochemical and
gene expression analyses.
Methods: We analyzed structure, turnover and microarchitecture, cyclooxygenase 2 (COX-2) levels and osteocyte
apoptosis in 40 female rats divided as follows: 1) vehicle of methylprednisolone (vGC) + vehicle of risedronate
(vRis); 2) Ris 5 μg/Kg + vGC; 3) methylprednisolone (GC) 7 mg/Kg + vRis; 4) GC 7 mg/Kg +Ris 5 μg/Kg. In addition,
we evaluated cell proliferation and expression of COX-2 and bone alkaline phosphatase (b-ALP) genes in bone
marrow cells and MLO-y4 osteocytes treated with Ris alone or in co-treatment with the selective COX-2 inhibitor
NS-398 or with dexametasone.
Results: Ris reduced apoptosis induced by GC of osteocytes (41% vs 86%, P < 0.0001) and increased COX-2
expression with respect to controls (Immuno-Hystochemical Score (IHS): 8.75 vs 1.00, P < 0.0001). These positive
effects of Ris in bone formation were confirmed by in vitro data as the viability and expression of b-ALP gene in
bone marrow cells resulted increased in a dose dependent manner.
Conclusions: These findings suggest a positive effect of Ris in bone formation and support the hypothesis that the
up-regulation of COX-2 could be an additional mechanism of anabolic effect of Ris.
- Id prodotto:
-
58066
- Handle IRIS:
-
11562/346048
- depositato il:
-
29 febbraio 2012
- ultima modifica:
-
15 novembre 2022
- Citazione bibliografica:
-
Valenti, Maria Teresa; Giannini, S; Donatelli, Luca; Zanatta, Mirko; Bertoldo, Francesco; Sella, S; Vilei, Mt; Ossi, E; Realdi, G; LO CASCIO, Vincenzo; DALLE CARBONARE, Luca Giuseppe,
The effect of risedronate on osteogenic lineage is mediated by cyclooxygenase-2 gene upregulation
«ARTHRITIS RESEARCH & THERAPY»
, vol.
12
, n.
4
,
2010
,
pp. R163-R176
Consulta la scheda completa presente nel
repository istituzionale della Ricerca di Ateneo